A Double-Blind, Randomized Study of Safety and Efficacy of OnabotulinumtoxinA (OnaBoNT-A) versus Oral Oxybutynin in SCI Patients with NDO (11-09-10-04)
Abstract
After initial difficulty recruiting, a revised IRB protocol that included a decrease in patient visits and the number of urodynamic studies was approved on August 22, 2013 which allows for mailing of letters to local spinal cord injured patients at MEDVAMC. One hundred letters were mailed out on October 1st, 2013. Five responses have been received thus far, 2 calls from a VA brochure. One patient has qualified. Two other possible patients have been identified for the study as well. A second batch of 157 letters was mailed out on October 18th, 2013.
Document Details
- Document Type
- Technical Report
- Publication Date
- Oct 01, 2013
- Accession Number
- ADA599466
Entities
People
- Christopher P. Smith
Organizations
- Baylor College of Medicine